Terms: = Pancreatic cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
126 results:
1. Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer.
Yang W; Chen H; Li G; Zhang T; Sui Y; Liu L; Hu J; Wang G; Chen H; Wang Y; Li X; Tan H; Kong R; Sun B; Li L
J Transl Med; 2023 Dec; 21(1):903. PubMed ID: 38082307
[TBL] [Abstract] [Full Text] [Related]
2. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
Croft W; Pearce H; Margielewska-Davies S; Lim L; Nicol SM; Zayou F; Blakeway D; Marcon F; Powell-Brett S; Mahon B; Merard R; Zuo J; Middleton G; Roberts K; Brown RM; Moss P
Elife; 2023 Jun; 12():. PubMed ID: 37350578
[TBL] [Abstract] [Full Text] [Related]
3. Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma.
Yagi K; Shimada S; Akiyama Y; Hatano M; Asano D; Ishikawa Y; Ueda H; Watanabe S; Akahoshi K; Ono H; Tanabe M; Tanaka S
Sci Rep; 2023 Jun; 13(1):9449. PubMed ID: 37296228
[TBL] [Abstract] [Full Text] [Related]
4. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma.
Xu Z; Liu Y; Pan Z; Qin L
Histol Histopathol; 2024 Feb; 39(2):263-277. PubMed ID: 37232506
[TBL] [Abstract] [Full Text] [Related]
5. An Inflection Point in cancer Protein Biomarkers: What was and What's Next.
Barker AD; Alba MM; Mallick P; Agus DB; Lee JSH
Mol Cell Proteomics; 2023 Jul; 22(7):100569. PubMed ID: 37196763
[TBL] [Abstract] [Full Text] [Related]
6. Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology.
Panni UY; Chen MY; Zhang F; Cullinan DR; Li L; James CA; Zhang X; Rogers S; Alarcon A; Baer JM; Zhang D; Gao F; Miller CA; Gong Q; Lim KH; DeNardo DG; Goedegebuure SP; Gillanders WE; Hawkins WG
Cancer Immunol Immunother; 2023 Aug; 72(8):2813-2827. PubMed ID: 37179276
[TBL] [Abstract] [Full Text] [Related]
7. Elevated PAF1-RAD52 axis confers chemoresistance to human cancers.
Rauth S; Ganguly K; Atri P; Parte S; Nimmakayala RK; Varadharaj V; Nallasamy P; Vengoji R; Ogunleye AO; Lakshmanan I; Chirravuri R; Bessho M; Cox JL; Foster JM; Talmon GA; Bessho T; Ganti AK; Batra SK; Ponnusamy MP
Cell Rep; 2023 Feb; 42(2):112043. PubMed ID: 36709426
[TBL] [Abstract] [Full Text] [Related]
8. Cisplatin and gemcitabine exert opposite effects on immunotherapy with PD-1 antibody in K-ras-driven cancer.
Glorieux C; Xia X; You X; Wang Z; Han Y; Yang J; Noppe G; Meester C; Ling J; Robert A; Zhang H; Li SP; Wang H; Chiao PJ; Zhang L; Li X; Huang P
J Adv Res; 2022 Sep; 40():109-124. PubMed ID: 36100320
[TBL] [Abstract] [Full Text] [Related]
9. Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.
Vijayakurup V; Maeng K; Lee HS; Meyer B; Burkett S; Nawab A; Dougherty MW; Jobin C; Mahmud I; Garrett TJ; Feely M; Lee KB; Kaye FJ; Guijarro MV; Zajac-Kaye M
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36048542
[TBL] [Abstract] [Full Text] [Related]
10. Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for pancreatic Adenocarcinoma.
Xiong F; Guo T; Wang X; Wu G; Liu W; Wang Q; Wang B; Chen Y
Dis Markers; 2022; 2022():8159537. PubMed ID: 35958278
[TBL] [Abstract] [Full Text] [Related]
11. Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential.
Endo Y; Suzuki K; Kimura Y; Tamaki S; Aizawa H; Abe I; Watanabe F; Kato T; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T
Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35419613
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in pancreatic Ductal Adenocarcinoma.
Zhang Y; Liu Q; Cui M; Wang M; Hua S; Gao J; Liao Q
Front Immunol; 2021; 12():774435. PubMed ID: 35046938
[TBL] [Abstract] [Full Text] [Related]
13. HO-1 Protects Remnant Liver against Dysfunction after Major Hepatectomy in Humans.
He N; Sun X; Hu Z; Wang F; Zhang Y; Chen X; Wu H; Zhou X; Zheng S; Jin X
J Invest Surg; 2022 May; 35(5):1163-1169. PubMed ID: 34651541
[TBL] [Abstract] [Full Text] [Related]
14. A Critical Assessment of the Association between HLA-G Expression by Carcinomas and clinical outcome.
van de Water RB; Krijgsman D; Houvast RD; Vahrmeijer AL; Kuppen PJK
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361031
[TBL] [Abstract] [Full Text] [Related]
15. Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression.
Cheng CS; Tan HY; Wang N; Chen L; Meng Z; Chen Z; Feng Y
Clin Transl Med; 2021 Jun; 11(6):e467. PubMed ID: 34185423
[TBL] [Abstract] [Full Text] [Related]
16. Improving Gemcitabine Sensitivity in pancreatic cancer Cells by Restoring miRNA-217 Levels.
Panebianco C; Trivieri N; Villani A; Terracciano F; Latiano TP; Potenza A; Perri F; Binda E; Pazienza V
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33925948
[TBL] [Abstract] [Full Text] [Related]
17. Leukocyte Heterogeneity in pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with clinical outcome.
Liudahl SM; Betts CB; Sivagnanam S; Morales-Oyarvide V; da Silva A; Yuan C; Hwang S; Grossblatt-Wait A; Leis KR; Larson W; Lavoie MB; Robinson P; Dias Costa A; Väyrynen SA; Clancy TE; Rubinson DA; Link J; Keith D; Horton W; Tempero MA; Vonderheide RH; Jaffee EM; Sheppard B; Goecks J; Sears RC; Park BS; Mori M; Nowak JA; Wolpin BM; Coussens LM
Cancer Discov; 2021 Aug; 11(8):2014-2031. PubMed ID: 33727309
[TBL] [Abstract] [Full Text] [Related]
18. Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma.
Nguyen PHD; Ma S; Phua CZJ; Kaya NA; Lai HLH; Lim CJ; Lim JQ; Wasser M; Lai L; Tam WL; Lim TKH; Wan WK; Loh T; Leow WQ; Pang YH; Chan CY; Lee SY; Cheow PC; Toh HC; Ginhoux F; Iyer S; Kow AWC; Young Dan Y; Chung A; Bonney GK; Goh BKP; Albani S; Chow PKH; Zhai W; Chew V
Nat Commun; 2021 Jan; 12(1):227. PubMed ID: 33431814
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression.
Bi Y; Shirure VS; Liu R; Cunningham C; Ding L; Meacham JM; Goedegebuure SP; George SC; Fields RC
Integr Biol (Camb); 2020 Sep; 12(9):221-232. PubMed ID: 32930334
[TBL] [Abstract] [Full Text] [Related]
20. Periostin, tenascin, osteopontin isoforms in long- and non-long survival patients with pancreatic cancer: a pilot study.
Fiorino S; Visani M; Masetti M; Acquaviva G; Tallini G; De Leo A; Fornelli A; Ragazzi M; Vasuri F; Grifoni D; Argento CM; Maloberti T; Ravaioli M; Fabbri C; Jovine E; Pession A; de Biase D
Mol Biol Rep; 2020 Oct; 47(10):8235-8241. PubMed ID: 32886326
[TBL] [Abstract] [Full Text] [Related]
[Next]
